Pacemaker Type Selection

Primary Decision Algorithm

The American College of Cardiology recommends dual-chamber pacing (DDD) over single-chamber ventricular pacing (VVI) in patients with intact AV conduction (Class I, Level of Evidence A) 1, 2
Dual-chamber pacing is superior to ventricular pacing for reducing atrial fibrillation risk, preventing pacemaker syndrome, and improving quality of life 1, 3
Single-chamber atrial pacing (AAI) may be considered in highly selected patients with normal AV and ventricular conduction (Class IIb) 1, 2
The American College of Cardiology recommends avoiding dual-chamber or atrial pacing in patients with permanent or longstanding persistent AF where rhythm restoration is not planned (Class III) 1, 2
Dual-chamber pacing is recommended as first-line therapy for AV block (Class I, Level of Evidence C) 1, 2
Single-chamber ventricular pacing is acceptable in specific situations, such as sedentary patients or significant medical comorbidities limiting life expectancy (Class I, Level of Evidence B) 1, 2
Single-lead VDD pacing can be useful in patients with normal sinus node function and AV block, particularly younger patients with congenital AV block (Class IIa) 1, 2
VVI pacing is appropriate following AV junction ablation or when ablation is planned for AF rate control (Class IIa) 1, 2

For patients with permanent atrial fibrillation, single-chamber ventricular (VVI) pacing is recommended when there is no significant atrial hemodynamic contribution (Class I) 4, 5
Dual-chamber pacing should not be used in permanent AF where rhythm restoration is not planned (Class III) 1, 2
Dual-chamber or single-chamber ventricular pacing can be useful for patients with hypersensitive carotid sinus syndrome (Class I, Level of Evidence C) 1, 2
AAI pacing is not recommended for patients with hypersensitive carotid sinus syndrome (Class IIa) 1, 2
Dual-chamber pacing can be useful for patients with neurocardiogenic syncope (Class I, Level of Evidence C) 1, 2
AAI pacing is not recommended for patients with neurocardiogenic syncope (Class IIa) 1, 2
Dual-chamber or atrial pacing is recommended over ventricular pacing for symptomatic or high-risk patients with long QT syndrome (Class I, Level of Evidence C) 1, 2
Dual-chamber pacing can be useful for medically refractory, symptomatic patients with significant resting or provoked LVOT obstruction due to hypertrophic cardiomyopathy (Class I, Level of Evidence C) 1, 2

Patient-specific considerations, such as cardiac conduction abnormality type and severity, presence and severity of comorbidities, coronary heart disease and angina status, degree of left ventricular dysfunction, current and anticipated future drug therapy, and anticipated activity level, should be taken into account when selecting a pacemaker 4, 5, 6
Technical considerations, such as vascular access limitations, availability of follow-up services, expertise of implant team, and cost considerations, should also be considered when selecting a pacemaker 4, 5, 6

Pacemaker syndrome occurs with loss of AV synchrony in ventricular pacing, causing symptoms like lightheadedness or syncope, and is a critical reason to avoid VVI pacing in patients with intact atrial function 2, 4, 5
Minimizing ventricular pacing is recommended in patients with SND and intact AV conduction to prevent AF, and dual-chamber pacemakers should be programmed to minimize ventricular pacing (Class IIa, Level of Evidence B) 1, 2
Selecting a pacemaker with capabilities that may be needed in the future, even if not required at implantation, is recommended 6
Consider upgrading to CRT-P or CRT-D if the patient is likely to qualify shortly, such as post-MI with extremely low LVEF 6

The American College of Cardiology recommends dual-chamber pacemakers as first-line therapy for patients with bifascicular block and AV conduction disease, as they restore both AV synchrony and chronotropic competence (Class I indication) 7
Dual-chamber pacemakers maintain AV synchrony, which contributes significantly to cardiac output, increasing stroke volume by as much as 50% and decreasing left atrial pressure by up to 25%, particularly important in patients with diastolic dysfunction or left ventricular hypertrophy 7
Single-lead VDD pacing can be useful in patients with bifascicular block who have normal sinus node function and AV block (Class IIa), particularly in younger patients with congenital AV block 7
VDD pacing restores both AV synchrony and chronotropic competence while requiring only a single ventricular lead with atrial sensing capability 7
VVI pacing is acceptable only in specific situations: sedentary patients, significant medical comorbidities limiting life expectancy, or following AV junction ablation for atrial fibrillation rate control 7
Dual-chamber pacing should NOT be used in patients with permanent or longstanding persistent atrial fibrillation where rhythm restoration is not planned (Class III) 7

Pacemaker syndrome occurs with loss of AV synchrony in ventricular pacing, causing symptoms including lightheadedness, syncope, fatigue, and hemodynamic compromise due to ventriculoatrial conduction or atrial contraction against closed AV valves 7
This is a critical reason to avoid VVI pacing in patients with intact atrial function and bifascicular block 7

Pacing relieves neurological symptoms from bradycardia but does not reduce sudden death in this population, as death is often due to underlying heart disease rather than bradyarrhythmia 8